The authors designed a non-human leukocyte antigen (HLA) antibody detection immunoassay using HLA class I and II–deficient glomerular endothelial cells that had been previously generated through CRISPR/Cas9-induced B2M and CIITA gene disruption.
[Journal of the American Society of Nephrology]
7992332
{7992332:CCCCCCCC}
apa
50
1
169542
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/